Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (31-40 of 349) with videos related to

Pageof 35
Sort By:
BMJ (Clinical Research Ed.)|May 24, 2008
How to interpret figures in reports of clinical trialsStuart J Pocock, Thomas G Travison, Lisa M Wruck
Trials|November 21, 2007
Figures in clinical trial reports: current practice & scope for improvementStuart J Pocock, Thomas G Travison, Lisa M Wruck
Nature Reviews. Cardiology|December 16, 2022
The need for new clinical trials of old cardiovascular drugsChristopher B Granger, Stuart J Pocock, Bernard J Gersh
Epidemiologic Perspectives & Innovations : EP+I|October 19, 2010
Categorisation of continuous risk factors in epidemiological publications: a survey of current practiceElizabeth L Turner, Joanna E Dobson, Stuart J Pocock
Journal of the American College of Cardiology|December 25, 2015
Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, Tim C Clayton, Gregg W Stone
Journal of the American College of Cardiology|January 1, 2016
Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, Tim C Clayton, Gregg W Stone
Journal of the American College of Cardiology|December 17, 2015
Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
Journal of the American College of Cardiology|December 15, 2015
Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
BMJ (Clinical Research Ed.)|February 9, 2011
Strategy for intention to treat analysis in randomised trials with missing outcome dataIan R White, Nicholas J Horton, James Carpenter, et al.
Diabetes Care|June 28, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)Robert H Knopp, Michael d'Emden, Johan G Smilde, et al.
Pageof 35

Showing results (31-40 of 349) with videos related to

Sort By:
Pageof 35
BMJ (Clinical Research Ed.)|May 24, 2008
How to interpret figures in reports of clinical trialsStuart J Pocock, Thomas G Travison, Lisa M Wruck
Trials|November 21, 2007
Figures in clinical trial reports: current practice & scope for improvementStuart J Pocock, Thomas G Travison, Lisa M Wruck
Nature Reviews. Cardiology|December 16, 2022
The need for new clinical trials of old cardiovascular drugsChristopher B Granger, Stuart J Pocock, Bernard J Gersh
Epidemiologic Perspectives & Innovations : EP+I|October 19, 2010
Categorisation of continuous risk factors in epidemiological publications: a survey of current practiceElizabeth L Turner, Joanna E Dobson, Stuart J Pocock
Journal of the American College of Cardiology|December 25, 2015
Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, Tim C Clayton, Gregg W Stone
Journal of the American College of Cardiology|January 1, 2016
Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, Tim C Clayton, Gregg W Stone
Journal of the American College of Cardiology|December 17, 2015
Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
Journal of the American College of Cardiology|December 15, 2015
Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical TrialsStuart J Pocock, John J V McMurray, Tim J Collier
BMJ (Clinical Research Ed.)|February 9, 2011
Strategy for intention to treat analysis in randomised trials with missing outcome dataIan R White, Nicholas J Horton, James Carpenter, et al.
Diabetes Care|June 28, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)Robert H Knopp, Michael d'Emden, Johan G Smilde, et al.
Pageof 35